Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
08037 China Biotech Services
1.100
-0.020-1.79%
Symbol
08037
Company Name
China Biotech Services
ISIN
BMG2152F1014
Listing Date
06/17/2004
Establishment Date
06/05/2003
Registration
Bermuda
Chairman
Xiaolin Liu
Secretary
Miaochun Wang
Audit Institution
Luo Shenmei accounting firm
Company Category
Overseas registration of Mainland Individuals control
Registered Office
Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda
Head Office and Principal Place of Business
Room 1904-05A, 19 / F, Sino Plaza, 257 Gloucester Road, Causeway Bay, Hong Kong
Fiscal Year Ends
12-31
Employees
295
Market
GEM
Phone
(852)21492588
Fax
(852)24999932
Email
info@ruikang.com.hk
Business
The main business of the Company is investment holding. The principal businesses of its subsidiaries are (I) providing medical laboratory testing services and health check-up services in Hong Kong, the PRC; (ii) providing tumor immunocytotherapy, immunocyte storage and health management services in the people's Republic of China (the "PRC"); (iii) manufacturing, R & D, sales and distribution of health related and pharmaceutical products in the PRC and Hong Kong, China; and (iv) providing insurance brokerage services.
Profile
China Biotechnology Services Holdings Limited was established as a Sino-foreign joint venture in China in 1996 and was listed on the gem of the Hong Kong Stock Exchange in June 2004 under the stock code 8037.HK, referred to as "China Biotechnology Services". The company was included in the Hong Kong MSCI Micro-share Index in May 2018. Our vision: Future biotechnology platform The layout of "accurate diagnosis: accurate Great Health Inspection system" and "accurate treatment: Car-T Integrated Industry chain" ▎ based on Guangdong-Hong Kong-Macau Greater Bay Area facing China and Europe and the United States Seize the historical opportunity of global precision medical development and strive to become a future biotechnology platform Company philosophy: Cover various human states of health, sub-health and disease, through the combination of individual life numbers and big data's life cycle table, recognize and control customer health throughout the life cycle, and formulate targeted intervention measures. make the disease knowable, controllable and treatable.
Company Overview
China Biotechnology Services Holdings Limited was established as a Sino-foreign joint venture in China in 1996 and was listed on the gem of the Hong Kong Stock Exchange in June 2004 under the stock code 8037.HK, referred to as "China Biotechnology Services". The company was included in the Hong Kong MSCI Micro-share Index in May 2018. Our vision: Future biotechnology platform The layout of "accurate diagnosis: accurate Great Health Inspection system" and "accurate treatment: Car-T Integrated Industry chain" ▎ based on Guangdong-Hong Kong-Macau Greater Bay Area facing China and Europe and the United States Seize the historical opportunity of global precision medical development and strive to become a future biotechnology platform Company philosophy: Cover various human states of health, sub-health and disease, through the combination of individual life numbers and big data's life cycle table, recognize and control customer health throughout the life cycle, and formulate targeted intervention measures. make the disease knowable, controllable and treatable.
CEO: Xiaolin Liu
Market: GEM
Listing Date: 06/17/2004
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist